QuantiFERON-cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
Grace ThompsonPeter A BoanDuncan PurtillJulian P CooneyPaul CannellMatthew WrightMina JohnPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
Positive QFN-CMV at d100 and d150 strongly predicted freedom from csCMVi after these time points. QFN-CMV could be utilized to predict the need for pre-emptive therapy and CMV viral load monitoring after day 100 post-alloHCT.